Polycystic Ovary Syndrome (PCOS) is being renamed as Polymetabolic Ovary Syndrome (PMOS).
At first glance it might sound like a technical update, but it points to something much broader. Because PCOS was never just about ovaries.
Why the previous name fell short
For years PCOS focused the conversation on cysts and reproduction, but that framing has never reflected the full picture. Not everyone with PCOS has ovarian cysts and for many, the most persistent symptoms sit outside reproductive health entirely.
PCOS affects:
- hormonal regulation
- metabolic processes
- energy and weight
- mental health and mood
That’s why many clinicians and organisations have increasingly highlighted its system-wide impact. The name PMOS starts to reflect that reality
“PCOS was never just about ovaries”
Why naming matters in healthcare
Rather than just describing the condition, names shape how those conditions are understood, prioritised and treated.
When PCOS is positioned as a reproductive issue, care often follows that logic:
- symptoms are addressed individually within a specific department
- treatment becomes fragmented and blinkered
- underlying drivers are missed
The result is a disconnect between how the condition is experienced and how it is managed, and that disconnect shows up in patient outcomes.
The scale of the gap
PCOS affects around 1 in 10 women in the UK, making it one of the most common hormonal conditions. Despite that, many women:
- wait years for a diagnosis
- are passed between services
- or receive advice that focuses on one symptom at a time
This sits within a wider pattern in women’s health.
Research suggests 60% of women in the UK feel their symptoms have not been taken seriously by a healthcare professional. At the same time, the UK continues to face a significant gender health gap, with women spending more years in ill health compared to men. PCOS is part of that pattern, not separate from it.
“Rather than just describing the condition, names shape how those conditions are understood, prioritised and treated”
More than a reproductive condition
The shift to PMOS reflects what the evidence has been showing for some time:
This is not just a reproductive condition, but a metabolic and endocrine condition with wider health implications.
That includes links to:
- insulin resistance
- increased risk of type 2 diabetes
- cardiovascular health
- psychological wellbeing
In other words, it’s about how the body regulates and not just how it reproduces.
Check out our article: Polycystic ovary syndrome (PCOS) explained: A complex hormonal disorder from Dr Joanne Hobson, which deep dives causes, symptoms and treatments.
What needs to change next
Renaming PCOS is a step forward, but naming alone doesn’t change care. What matters is what follows.
That means earlier recognition of symptoms, clearer explanations of what’s happening in the body and care that connects, rather than separates, different aspects of health. When a condition is understood as system-wide, the response to it needs to be system-wide too.
“This isn’t just about terminology, but about opening the door to better care”
Where this leaves women now
For many, this shift simply validates what they’ve already been experiencing – that PCOS was never just about ovaries and that the way it has been framed has shaped the care they received.
The move to PMOS is an acknowledgement.
The next step is ensuring that acknowledgement translates into:
- better diagnosis
- more joined-up support
- and fewer women left trying to make sense of it alone
This isn’t just about terminology, but about opening the door to better care. Earlier recognition, clearer explanations and support that reflects how women’s bodies actually work.
If the conversation is starting to shift, the opportunity now is to make sure care shifts with it.
